 RAMSEY, N.J. and BOCA RATON, Fla., Sept. 02, 2021 GLOBE NEWSWIRE -- ADMA Biologics, Inc. Nasdaq: ADMA the Company, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that Adam Grossman, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021, at 12:30 p.m. ET. 